Related Experiment Video
Updated: May 15, 2026

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
Animal models of serotonergic psychedelics
James B Hanks1, Javier González-Maeso
1Department of Psychiatry, Friedman Brain Institute, Mount Sinai School of Medicine, New York, New York 10029, United States.
Abstract:
The serotonin 5-HT(2A) receptor is the major target of psychedelic drugs such as lysergic acid diethylamide (LSD), mescaline, and psilocybin. Serotonergic psychedelics induce profound effects on cognition, emotion, and sensory processing that often seem uniquely human. This raises questions about the validity of animal models of psychedelic drug action. Nonetheless, recent findings suggest behavioral abnormalities elicited by psychedelics in rodents that predict such effects in humans. Here we review the behavioral effects induced by psychedelic drugs in rodent models, discuss the translational potential of these findings, and define areas where further research is needed to better understand the molecular mechanisms and neuronal circuits underlying their neuropsychological effects.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
CNS Stimulants: Psychedelic Agents
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
